The expression of TGF‐β and the mesenchymal marker proteins such as N‐Cadherin and VIM in the xenograft tumours were significantly reduced in all treatment regimen groups as determined by both western blot (Figure 7A,B) and immunohistochemistry (Figure 7C). Here, TGFB1 is linked to neoplasm.